Supported by an educational grant from Axsome Therapeutics, Inc.

News

Pharmacogenomic Test Improves MDD Response and Remission Outcomes

Clinician use of a specific weighted multigene pharmacogenomic (PGx) test significantly improved outcomes in adult patients with

All News

Post Partum Hormonal Contraception Use Linked With Heightened Depression Risk

The initiation of hormonal contraception post partum was associated with an immediate increase in

New Study Finds Quetiapine More Effective Than Lithium in Reducing Treatment-Resistant Depression Symptoms

Quetiapine may be more clinically effective than lithium as an augmentation option for reducing symptoms of treatment-resistant depression (TRD), a type of

Dietary Intervention May Alleviate Symptoms of Depression

Adhering to specific dietary patterns, including the Mediterranean diet, may reduce symptoms of

Accelerated Theta-Burst Stimulation Protocol Improves Treatment-Resistant Depression

A novel 78-minute accelerated theta-burst stimulation (aTBS) protocol reduced depression severity in patients with treatment-resistant depression (TRD), according to resu